Dariusz Rokicki

Dr. Dariusz Rokicki


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Pharmacological Reports
Verified
Journal Article
Closed access
DRDorota Magdalena Radomska-Leśniewska
Dorota Magdalena Radomska-Leśniewska
AHAgata Hevelke
Agata Hevelke
PSPiotr Jan Skopiński
Piotr Jan Skopiński
BBBarbara Joanna Bałan
Barbara Joanna Bałan
Jarosław JóźwiakJarosław Jóźwiak
Jarosław Jóźwiak
ABAgata Bialoszewska-Magnusson
Agata Bialoszewska-Magnusson

15 December 2014 in Central European Journal of Immunology
Verified
Journal Article
Open access
DRDariusz Rokicki
Dariusz Rokicki
Robert ZdanowskiRobert Zdanowski
Robert Zdanowski
SLSławomir Lewicki
Sławomir Lewicki
MLMonika Leśniak
Monika Leśniak
MSMilena Suska
Milena Suska
PSPiotr Jan Skopiński
Piotr Jan Skopiński
Angiogenesis is a multi-stage process of new vessel development which involves migration, proliferation and differentiation of endothelial cells. Pathological angiogenesis plays a crucial role in the pathomechanism of various ischemic, malignant and inflammatory disorders. Among eye diseases, macular degeneration (AMD) and proliferative diabetic retinopathy are a major public health issue as the most common causes of blindness. Since angiogenesis plays a crucial role in these conditions, there has been an increased interest in evaluating anti-angiogenic agents in their treatment. The polyphenol resveratrol found in the skin of red grapes, red wine, peanuts and other natural sources, controls proliferation of the cells, induces differentiation and induces apoptosis in various malignant cell lines. Modulation of angiogenesis by this compound has been considered as a very exciting topic and subject of further investigations. The aim of our study was in vitro assessment of resveratrol’s influence on proliferation, migration and invasion of an immortalized murine endothelial cell line from peripheral lymph node HEC clone a10. Resveratrol was shown to inhibit the proliferation of the endothelial cells in MTT (at 1, 10 and 50 µM) and AlamarBlue (at 50 µM) assays, and at a concentration of 50 µM significantly inhibited migration of endothelial cells. A concentration-dependent decrease in invasion potential of endothelial cells incubated with resveratrol 10 µM and 50 µM was detected. These promising in vitro results might encourage investigators to test efficacy and safety of resveratrol more extensively in the clinical practice, as a natural and safe anti-angiogenic agent.

8 November 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
MLMonika Leśniak
Monika Leśniak
DRDariusz Rokicki
Dariusz Rokicki
ASAgnieszka Synowiec
Agnieszka Synowiec
AFAleksandra Filipiak
Aleksandra Filipiak
PSPiotr Skopiński
Piotr Skopiński
SLSławomir Lewicki
Sławomir Lewicki
Age-related macular degeneration (AMD) and diabetic retinopathy are the leading cause of blindness in developed countries. Pathological angiogenesis has a causal role in these eye diseases. Resveratrol (RSV), a plant-derived polyphenol, has anti-proliferative and anti-angiogenic properties that could improve its management. Here, the effects of various concentrations of RSV (1, 5, 10, 50, 100 µM) were compared in two types of cell lines: HECa10 (endothelial cell line) and ARPE-19 (retinal pigment epithelial cell line). We assayed the impact on proliferation rate, viability, cell cycle progression, and secretion of selected proangiogenic factors VEGF and bFGF. We show that lower concentrations of RSV (1, 5, 10 µM) had no effect on proliferation, viability or cell cycle progression in HECa10 cells. However, higher concentrations (50, 100 µM) significantly enhanced the reduction in the cell number and stimulated apoptosis. In ARPE-19 cells, lower concentrations of RSV increased the rate of proliferation, while higher concentrations had no effect on proliferation and viability. Both ARPE-19 and HECa10 cell lines were affected to different degrees in the secretion of proangiogenic cytokines: reducing VEGF and enhancing bFGF secretion. These results suggest that RSV may be useful in the prevention or treatment of pathological angiogenesis in eye disorders.